Theranos Inc. and its founder pledged to stay out of the blood-testing business for at least two years in exchange for reduced penalties from federal health authorities, in an agreement that resolves a year-long regulatory impasse. The main lab regulator first had proposed barring Elizabeth Holmes from the medical-lab business for two years in March 2016 after the company failed to correct testing problems at its main lab in Newark,...

Source: Wall Street Journal April 17, 2017 23:37 UTC